# RH (RH) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Consumer Cyclical / Specialty Retail. Price $147.99, market value $2.8 billion.

## Valuation
- **P/E (trailing): 28.6×** (5-yr avg 44.8×, 3-yr avg 63.5×). RH trades at 28.6× trailing earnings, well below its own five-year average of 44.8×: cheap by its own standards. The Consumer Cyclical median in the September 2026 study was 19.5×. Forward P/E is 16.3×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.22**. A PEG of 0.22 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 0.8×**. Each dollar of revenue is priced at 0.8×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 49.1×**. The shares trade at 49.1× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **EV / EBITDA: 10.0×**. Enterprise value is 10.0× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: 8.3%** (5-yr avg 1.9%). Free cash flow equals 8.3% of the market value, above its five-year average of 1.9%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 3.5%**. The inverse of the P/E: 3.5% of the price is earned each year.

## Profitability
- **Gross margin: 43.5%**. RH keeps 43.5% of revenue after the direct cost of what it sells.
- **Operating margin: 10.7%**. 10.7% of revenue is left after running the business.
- **Net margin: 3.6%**. 3.6% of each dollar of sales reaches the bottom line.
- **Return on equity: 205.9%**. A 205.9% return on equity is extremely high; check whether buybacks or debt have shrunk the equity base, which flatters the ratio.
- **Return on invested capital: 11.9%**. Return on all capital, debt included, is 11.9%.
- **Return on assets: 2.1%**. Each dollar of assets produces 2.1% of profit.

## Growth
- **Revenue growth (1 yr): 8.1%** (3-yr -1.4%/yr, 5-yr 3.8%/yr). Revenue grew 8.1% over the last year, against 3.8% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 74.3%** (3-yr -31.8%/yr, 5-yr -8.7%/yr). Earnings per share rose 74.3%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): 3.1%/yr**. Free cash flow has compounded at 3.1% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Debt to equity: 39.58**. Debt is 39.58 times equity, a leveraged balance sheet that needs steady cash flow to service.
- **Net debt / EBITDA: 4.6×**. It would take 4.6 years of operating earnings to repay net borrowings, above the 3× level most lenders treat as comfortable.
- **Altman Z-score: 1.35**. A Z-score of 1.35 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. RH does not currently pay a dividend.

## Analyst view
- **Analyst consensus: hold** (17 analysts). 17 analysts cover RH; the consensus is hold, with an average price target of $178.06 (+20% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -37.1%** (YTD -17.4%, 3-mo 0.9%). The shares are down 37.1% over twelve months including dividends.
- **From 52-week high: -40.4%** (39.2% above the low). Trading 40% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 40**. An RSI of 40 is neutral.
- **Beta (1 yr): 2.12** (volatility 61%). Beta of 2.12 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=RH · Page: https://foliofundamentals.com/stocks/rh

Not investment advice.